CA2359641A1 - Chewing gum with dental health benefits employing calcium lactate - Google Patents
Chewing gum with dental health benefits employing calcium lactate Download PDFInfo
- Publication number
- CA2359641A1 CA2359641A1 CA002359641A CA2359641A CA2359641A1 CA 2359641 A1 CA2359641 A1 CA 2359641A1 CA 002359641 A CA002359641 A CA 002359641A CA 2359641 A CA2359641 A CA 2359641A CA 2359641 A1 CA2359641 A1 CA 2359641A1
- Authority
- CA
- Canada
- Prior art keywords
- chewing gum
- gum
- calcium lactate
- calcium
- ppm
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 235000015218 chewing gum Nutrition 0.000 title claims abstract description 75
- 229940112822 chewing gum Drugs 0.000 title claims abstract description 72
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 title claims abstract description 39
- 239000001527 calcium lactate Substances 0.000 title claims abstract description 39
- 229960002401 calcium lactate Drugs 0.000 title claims abstract description 39
- 235000011086 calcium lactate Nutrition 0.000 title claims abstract description 39
- 230000008901 benefit Effects 0.000 title description 12
- 230000037123 dental health Effects 0.000 title description 6
- 238000000034 method Methods 0.000 claims abstract description 25
- 239000000796 flavoring agent Substances 0.000 claims abstract description 22
- 210000003298 dental enamel Anatomy 0.000 claims abstract description 21
- 235000019634 flavors Nutrition 0.000 claims abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 13
- 210000003296 saliva Anatomy 0.000 claims description 17
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims description 11
- 229910001424 calcium ion Inorganic materials 0.000 claims description 11
- 239000003814 drug Substances 0.000 claims description 5
- 229940124597 therapeutic agent Drugs 0.000 claims description 5
- 230000001055 chewing effect Effects 0.000 claims description 4
- 230000001737 promoting effect Effects 0.000 claims description 3
- 230000000395 remineralizing effect Effects 0.000 claims description 3
- 239000011575 calcium Substances 0.000 description 25
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 23
- 229960005069 calcium Drugs 0.000 description 23
- 229910052791 calcium Inorganic materials 0.000 description 23
- 208000002925 dental caries Diseases 0.000 description 22
- 235000003599 food sweetener Nutrition 0.000 description 10
- 239000003765 sweetening agent Substances 0.000 description 10
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 9
- -1 softeners Substances 0.000 description 9
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 8
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 239000000600 sorbitol Substances 0.000 description 7
- 235000010356 sorbitol Nutrition 0.000 description 7
- 150000001720 carbohydrates Chemical class 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 235000013355 food flavoring agent Nutrition 0.000 description 6
- 230000003902 lesion Effects 0.000 description 6
- 239000006188 syrup Substances 0.000 description 6
- 235000020357 syrup Nutrition 0.000 description 6
- 239000004067 bulking agent Substances 0.000 description 5
- 229940077731 carbohydrate nutrients Drugs 0.000 description 5
- 235000014633 carbohydrates Nutrition 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 229920001971 elastomer Polymers 0.000 description 5
- 239000000806 elastomer Substances 0.000 description 5
- 210000000214 mouth Anatomy 0.000 description 5
- 229920003052 natural elastomer Polymers 0.000 description 5
- 229920001194 natural rubber Polymers 0.000 description 5
- 230000001953 sensory effect Effects 0.000 description 5
- 239000000811 xylitol Substances 0.000 description 5
- 229960002675 xylitol Drugs 0.000 description 5
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000008122 artificial sweetener Substances 0.000 description 4
- 235000021311 artificial sweeteners Nutrition 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 150000002314 glycerols Chemical class 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000000594 mannitol Substances 0.000 description 4
- 239000008188 pellet Substances 0.000 description 4
- 239000004014 plasticizer Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 229920003048 styrene butadiene rubber Polymers 0.000 description 4
- 150000005846 sugar alcohols Chemical class 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 3
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 3
- 229930195725 Mannitol Natural products 0.000 description 3
- 241000194019 Streptococcus mutans Species 0.000 description 3
- 239000002174 Styrene-butadiene Substances 0.000 description 3
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 3
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 3
- 239000000619 acesulfame-K Substances 0.000 description 3
- MTAZNLWOLGHBHU-UHFFFAOYSA-N butadiene-styrene rubber Chemical compound C=CC=C.C=CC1=CC=CC=C1 MTAZNLWOLGHBHU-UHFFFAOYSA-N 0.000 description 3
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 3
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 3
- 229960003260 chlorhexidine Drugs 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 239000000945 filler Substances 0.000 description 3
- 239000000413 hydrolysate Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000000845 maltitol Substances 0.000 description 3
- 235000010449 maltitol Nutrition 0.000 description 3
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 3
- 229940035436 maltitol Drugs 0.000 description 3
- 235000010355 mannitol Nutrition 0.000 description 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 229920002689 polyvinyl acetate Polymers 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000011115 styrene butadiene Substances 0.000 description 3
- 229920003051 synthetic elastomer Polymers 0.000 description 3
- 229960003500 triclosan Drugs 0.000 description 3
- 235000010447 xylitol Nutrition 0.000 description 3
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 3
- XMGQYMWWDOXHJM-JTQLQIEISA-N (+)-α-limonene Chemical compound CC(=C)[C@@H]1CCC(C)=CC1 XMGQYMWWDOXHJM-JTQLQIEISA-N 0.000 description 2
- NUFKRGBSZPCGQB-FLBSXDLDSA-N (3s)-3-amino-4-oxo-4-[[(2r)-1-oxo-1-[(2,2,4,4-tetramethylthietan-3-yl)amino]propan-2-yl]amino]butanoic acid;pentahydrate Chemical class O.O.O.O.O.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C NUFKRGBSZPCGQB-FLBSXDLDSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- 239000004377 Alitame Chemical class 0.000 description 2
- 108010011485 Aspartame Proteins 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 240000000896 Dyera costulata Species 0.000 description 2
- 101000801619 Homo sapiens Long-chain-fatty-acid-CoA ligase ACSBG1 Proteins 0.000 description 2
- 229920001908 Hydrogenated starch hydrolysate Polymers 0.000 description 2
- 102100033564 Long-chain-fatty-acid-CoA ligase ACSBG1 Human genes 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 240000002636 Manilkara bidentata Species 0.000 description 2
- 244000024873 Mentha crispa Species 0.000 description 2
- 235000014749 Mentha crispa Nutrition 0.000 description 2
- 244000246386 Mentha pulegium Species 0.000 description 2
- 235000016257 Mentha pulegium Nutrition 0.000 description 2
- 235000004357 Mentha x piperita Nutrition 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 229920001100 Polydextrose Polymers 0.000 description 2
- 229920002367 Polyisobutene Polymers 0.000 description 2
- 108010009736 Protein Hydrolysates Proteins 0.000 description 2
- 239000004376 Sucralose Substances 0.000 description 2
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 235000019409 alitame Nutrition 0.000 description 2
- 108010009985 alitame Chemical class 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 239000000605 aspartame Substances 0.000 description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 2
- 235000010357 aspartame Nutrition 0.000 description 2
- 229960003438 aspartame Drugs 0.000 description 2
- 235000016302 balata Nutrition 0.000 description 2
- 235000010634 bubble gum Nutrition 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- GLVVKKSPKXTQRB-UHFFFAOYSA-N ethenyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC=C GLVVKKSPKXTQRB-UHFFFAOYSA-N 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 229960002737 fructose Drugs 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000008123 high-intensity sweetener Substances 0.000 description 2
- 235000001050 hortel pimenta Nutrition 0.000 description 2
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- 244000005706 microflora Species 0.000 description 2
- 235000013615 non-nutritive sweetener Nutrition 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 2
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical class OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
- 239000001259 polydextrose Substances 0.000 description 2
- 235000013856 polydextrose Nutrition 0.000 description 2
- 229940035035 polydextrose Drugs 0.000 description 2
- 239000011118 polyvinyl acetate Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 239000003760 tallow Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- GRWFGVWFFZKLTI-UHFFFAOYSA-N α-pinene Chemical compound CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- WTARULDDTDQWMU-RKDXNWHRSA-N (+)-β-pinene Chemical compound C1[C@H]2C(C)(C)[C@@H]1CCC2=C WTARULDDTDQWMU-RKDXNWHRSA-N 0.000 description 1
- WTARULDDTDQWMU-IUCAKERBSA-N (-)-Nopinene Natural products C1[C@@H]2C(C)(C)[C@H]1CCC2=C WTARULDDTDQWMU-IUCAKERBSA-N 0.000 description 1
- KVHQNWGLVVERFR-ACMTZBLWSA-N (3s)-3-amino-4-[[(2s)-1-methoxy-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobutanoic acid;6-methyl-2,2-dioxooxathiazin-4-one Chemical compound CC1=CC(=O)[NH2+]S(=O)(=O)O1.[O-]C(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 KVHQNWGLVVERFR-ACMTZBLWSA-N 0.000 description 1
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- GRWFGVWFFZKLTI-IUCAKERBSA-N 1S,5S-(-)-alpha-Pinene Natural products CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 1
- LOVYCUYJRWLTSU-UHFFFAOYSA-N 2-(3,4-dichlorophenoxy)-n,n-diethylethanamine Chemical compound CCN(CC)CCOC1=CC=C(Cl)C(Cl)=C1 LOVYCUYJRWLTSU-UHFFFAOYSA-N 0.000 description 1
- KVZLHPXEUGJPAH-UHFFFAOYSA-N 2-oxidanylpropanoic acid Chemical compound CC(O)C(O)=O.CC(O)C(O)=O KVZLHPXEUGJPAH-UHFFFAOYSA-N 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- 239000000120 Artificial Saliva Substances 0.000 description 1
- 239000001736 Calcium glycerylphosphate Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229920001412 Chicle Polymers 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 235000019499 Citrus oil Nutrition 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 240000001238 Gaultheria procumbens Species 0.000 description 1
- 235000007297 Gaultheria procumbens Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004378 Glycyrrhizin Chemical class 0.000 description 1
- 244000043261 Hevea brasiliensis Species 0.000 description 1
- VHOQXEIFYTTXJU-UHFFFAOYSA-N Isobutylene-isoprene copolymer Chemical compound CC(C)=C.CC(=C)C=C VHOQXEIFYTTXJU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 240000001794 Manilkara zapota Species 0.000 description 1
- 235000011339 Manilkara zapota Nutrition 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 108050004114 Monellin Proteins 0.000 description 1
- 235000007265 Myrrhis odorata Nutrition 0.000 description 1
- 239000004384 Neotame Substances 0.000 description 1
- GFRROZIJVHUSKZ-FXGMSQOLSA-N OS I Natural products C[C@@H]1O[C@@H](O[C@H]2[C@@H](O)[C@@H](CO)O[C@@H](OC[C@@H](O)[C@@H](O)[C@@H](O)CO)[C@@H]2NC(=O)C)[C@H](O)[C@H](O)[C@H]1O GFRROZIJVHUSKZ-FXGMSQOLSA-N 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 241001495453 Parthenium argentatum Species 0.000 description 1
- 240000004760 Pimpinella anisum Species 0.000 description 1
- 235000012550 Pimpinella anisum Nutrition 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- WTARULDDTDQWMU-UHFFFAOYSA-N Pseudopinene Natural products C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- CPGKMLVTFNUAHL-UHFFFAOYSA-N [Ca].[Ca] Chemical compound [Ca].[Ca] CPGKMLVTFNUAHL-UHFFFAOYSA-N 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- YGCFIWIQZPHFLU-UHFFFAOYSA-N acesulfame Chemical class CC1=CC(=O)NS(=O)(=O)O1 YGCFIWIQZPHFLU-UHFFFAOYSA-N 0.000 description 1
- 229960005164 acesulfame Drugs 0.000 description 1
- 230000002053 acidogenic effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 1
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 230000003610 anti-gingivitis Effects 0.000 description 1
- 230000002882 anti-plaque Effects 0.000 description 1
- 229960001504 aspartame acesulfame Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229930006722 beta-pinene Natural products 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229920005549 butyl rubber Polymers 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- UHHRFSOMMCWGSO-UHFFFAOYSA-L calcium glycerophosphate Chemical compound [Ca+2].OCC(CO)OP([O-])([O-])=O UHHRFSOMMCWGSO-UHFFFAOYSA-L 0.000 description 1
- 229940095618 calcium glycerophosphate Drugs 0.000 description 1
- 235000019299 calcium glycerylphosphate Nutrition 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- HUSUHZRVLBSGBO-UHFFFAOYSA-L calcium;dihydrogen phosphate;hydroxide Chemical compound O.[Ca+2].OP([O-])([O-])=O HUSUHZRVLBSGBO-UHFFFAOYSA-L 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 239000010500 citrus oil Substances 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 229910052570 clay Inorganic materials 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 238000005354 coacervation Methods 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 239000000625 cyclamic acid and its Na and Ca salt Chemical class 0.000 description 1
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical class OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 1
- 238000005115 demineralization Methods 0.000 description 1
- 230000002328 demineralizing effect Effects 0.000 description 1
- 239000000551 dentifrice Substances 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 229940099371 diacetylated monoglycerides Drugs 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- UXAYDBNWIBJTRO-UHFFFAOYSA-N ethenyl acetate;ethenyl dodecanoate Chemical compound CC(=O)OC=C.CCCCCCCCCCCC(=O)OC=C UXAYDBNWIBJTRO-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000004334 fluoridation Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 229960003082 galactose Drugs 0.000 description 1
- LCWMKIHBLJLORW-UHFFFAOYSA-N gamma-carene Natural products C1CC(=C)CC2C(C)(C)C21 LCWMKIHBLJLORW-UHFFFAOYSA-N 0.000 description 1
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
- 235000013773 glyceryl triacetate Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Chemical class C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Chemical class CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical class O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000008172 hydrogenated vegetable oil Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000011256 inorganic filler Substances 0.000 description 1
- 229910003475 inorganic filler Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229960004903 invert sugar Drugs 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N linoleic acid group Chemical group C(CCCCCCC\C=C/C\C=C/CCCCC)(=O)O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 229920003008 liquid latex Polymers 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 239000001683 mentha spicata herb oil Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N palmitic acid group Chemical group C(CCCCCCCCCCCCCCC)(=O)O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 238000003359 percent control normalization Methods 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001195 polyisoprene Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 239000011253 protective coating Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical class C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Chemical class 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 235000019721 spearmint oil Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 239000000892 thaumatin Substances 0.000 description 1
- 235000010436 thaumatin Nutrition 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229960002622 triacetin Drugs 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000005550 wet granulation Methods 0.000 description 1
- 239000009637 wintergreen oil Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
- A23G4/12—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
- A23G4/126—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing vitamins, antibiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A61K9/0058—Chewing gums
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0063—Periodont
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Inorganic Chemistry (AREA)
- Physiology (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Emergency Medicine (AREA)
- Birds (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Confectionery (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Abstract
A chewing gum and method for the remineralization of tooth enamel is provide d. The chewing gum comprises an insoluble base portion, a water soluble portion , a flavor, and a therapeutically effective amount of calcium lactate.
Description
SPECIFICATION
TITLE
"CHEWING GUM WITH DENTAL HEALTH BENEFITS
EMPLOYING CALCIUM LACTATE"
BACKGROUND OF THE INVENTION
The present invention relates generally to chewing gums. More specifically, the present invention relates to chewing gums that can provide dental benefits.
Except for the common cold, dental caries (tooth decay) is the most prevalent human disorder. See, The Merck Manual, Sixteenth Edition, p. 2480. Even though, many steps have been taken to reduce dental caries and tooth decay, such as fluoridation and improved dental care, tooth decay continues to be a significant problem.
This is especially true in the adult population; 80% of the tooth decay occurs in 20%
of the population. See Featherstone, An Updated Understanding of the Mechanism of Dental Decay and its Prevention, Nutrition Quarterly, Vol. 14, No. l, 1990, pp. 5-11.
To protect a normal tooth, a thin layer of dental enamel forms a protective coating over the tooth. This coating consists mainly of calcium, phosphate, and other ions in a hydroxyapatite-like structure. The enamel contains 2 to 5 percent carbonate;
this carbonate content snakes the enamel susceptible to acid dissolution. See, Featherstone, id. at 6.
The interaction of three factors is believed to result in dental caries: a susceptible tooth surface; the proper microflora; and a suitable substrate for the microflora. Although several acidogenic micro-organisms that are present in the mouth can initiate carious lesions, Streptococcus mutans is believed to be the primary pathogen. See, The Merck Manual, supra.
It is known that foods containing fermentable carbohydrates can promote dental caries. Tooth decay begins when the Streptococcus mutans, that reside principally in the plaque that adheres to a tooth surface, metabolize the fermentable carbohydrates consumed by the host. During the metabolism of the fermentable carbohydrates by the bacteria, lactic acid and other organic acids are secreted as a by-product.
These acids reduce the pH of the surrounding plaque/tooth environment.
When the pH of the plaque/tooth environment drops below a critical level of 5.5 to 5.7, hydroxyapatite (calcium phosphate hydroxide, Ca,o(P04)6(OH)2), the key component of tooth enamel, begins to dissolve. This critical pH can change depending on the concentration of the key ions. Typically, the dissolution begins below the tooth's porous surface.
With repeated acid attacks, caused by the further metabolism of fermentable carbohydrates by the bacteria, subsurface lesions expand. The body's natural remineralization mechanism, however, at this point, can still reverse the decay process.
But, if the lesions expand to the point that the enamel surface breaks, a cavity is formed and the process is no longer reversible.
The natural remineralization process involves, in part, the flow of saliva over the plaque. The saliva can raise the pH of the environment. Additionally, calcium and phosphate ions in the saliva precipitate out to replace the hydroxyapatite that was dissolved by the organic acids created during the metabolism of the fermentable carbohydrates.
However, typically, this remineralization process only occurs at significant levels when the pH is above the critical level.. Therefore, if the saliva does not sufficiently raise the pH, significant remineralization will not occur. But, the remineralization process may be enhanced by fluoride in the oral cavity that speeds up new crystal growth and makes a flurorapatite-like material that is precipitated on the surface of the crystals inside the caries lesion. See, Featherstone, id. at 7.
A number of salts have been reported in certain experiments to counteract demineralization. One of the difficulties is providing a viable vehicle for delivering the salts. Still further, a number of safety issues are raised by some of the salts.
Furthermore, sensory problems with respect to some of the salts prevent these salts from being taken on a regular basis by a patient to provide prophylactic benefits.
U.S. Patent No. 5,378,171 discloses a sugar chewing gum with dental health benefits that includes calcium glycerophosphate.
TITLE
"CHEWING GUM WITH DENTAL HEALTH BENEFITS
EMPLOYING CALCIUM LACTATE"
BACKGROUND OF THE INVENTION
The present invention relates generally to chewing gums. More specifically, the present invention relates to chewing gums that can provide dental benefits.
Except for the common cold, dental caries (tooth decay) is the most prevalent human disorder. See, The Merck Manual, Sixteenth Edition, p. 2480. Even though, many steps have been taken to reduce dental caries and tooth decay, such as fluoridation and improved dental care, tooth decay continues to be a significant problem.
This is especially true in the adult population; 80% of the tooth decay occurs in 20%
of the population. See Featherstone, An Updated Understanding of the Mechanism of Dental Decay and its Prevention, Nutrition Quarterly, Vol. 14, No. l, 1990, pp. 5-11.
To protect a normal tooth, a thin layer of dental enamel forms a protective coating over the tooth. This coating consists mainly of calcium, phosphate, and other ions in a hydroxyapatite-like structure. The enamel contains 2 to 5 percent carbonate;
this carbonate content snakes the enamel susceptible to acid dissolution. See, Featherstone, id. at 6.
The interaction of three factors is believed to result in dental caries: a susceptible tooth surface; the proper microflora; and a suitable substrate for the microflora. Although several acidogenic micro-organisms that are present in the mouth can initiate carious lesions, Streptococcus mutans is believed to be the primary pathogen. See, The Merck Manual, supra.
It is known that foods containing fermentable carbohydrates can promote dental caries. Tooth decay begins when the Streptococcus mutans, that reside principally in the plaque that adheres to a tooth surface, metabolize the fermentable carbohydrates consumed by the host. During the metabolism of the fermentable carbohydrates by the bacteria, lactic acid and other organic acids are secreted as a by-product.
These acids reduce the pH of the surrounding plaque/tooth environment.
When the pH of the plaque/tooth environment drops below a critical level of 5.5 to 5.7, hydroxyapatite (calcium phosphate hydroxide, Ca,o(P04)6(OH)2), the key component of tooth enamel, begins to dissolve. This critical pH can change depending on the concentration of the key ions. Typically, the dissolution begins below the tooth's porous surface.
With repeated acid attacks, caused by the further metabolism of fermentable carbohydrates by the bacteria, subsurface lesions expand. The body's natural remineralization mechanism, however, at this point, can still reverse the decay process.
But, if the lesions expand to the point that the enamel surface breaks, a cavity is formed and the process is no longer reversible.
The natural remineralization process involves, in part, the flow of saliva over the plaque. The saliva can raise the pH of the environment. Additionally, calcium and phosphate ions in the saliva precipitate out to replace the hydroxyapatite that was dissolved by the organic acids created during the metabolism of the fermentable carbohydrates.
However, typically, this remineralization process only occurs at significant levels when the pH is above the critical level.. Therefore, if the saliva does not sufficiently raise the pH, significant remineralization will not occur. But, the remineralization process may be enhanced by fluoride in the oral cavity that speeds up new crystal growth and makes a flurorapatite-like material that is precipitated on the surface of the crystals inside the caries lesion. See, Featherstone, id. at 7.
A number of salts have been reported in certain experiments to counteract demineralization. One of the difficulties is providing a viable vehicle for delivering the salts. Still further, a number of safety issues are raised by some of the salts.
Furthermore, sensory problems with respect to some of the salts prevent these salts from being taken on a regular basis by a patient to provide prophylactic benefits.
U.S. Patent No. 5,378,171 discloses a sugar chewing gum with dental health benefits that includes calcium glycerophosphate.
SUMMARY OF THE INVENTION
The present invention provides a composition and method for the remineralization of enamel. Pursuant to the present invention, sugar free chewing gum is provided that includes a therapeutically effective amount of calcium lactate.
It has been found that calcium lactate counteracts the decaying process.
Calcium lactate is believed to function by promoting remineralization of the tooth enamel caused by dental caries. Calcium lactate has been found to be an effective enamel remineralization agent that is acceptable from sensory and safety standpoints.
Pursuant to the present invention, calcium lactate can be used in chewing gum:
Chewing gum is an especially good vehicle for delivering calcium lactate because it can deliver the ingredient over prolonged periods of time. Additionally, chewing gum can be conveniently used almost anywhere, at anytime, as opposed to a rinse or dentifrices.
To this end, a method for remineralizing enamel is provided comprising the step of providing a chewing gum that includes a therapeutically effective amount of calcium lactate.
In an embodiment, two pieces of chewing gum are chewed at a time.
In an embodiment of the method, the gum is chewed at least twice a day.
In an embodiment of the method, the chewing gum produces a calcium ion concentration in the saliva of the mouth of the chewer of at least 200 ppm.
In an embodiment of the method, the gum is chewed for at least two minutes.
The present invention also provides a chewing gum for reducing the generation of dental caries comprising a water insoluble base, water soluble portion and flavor, and calcium lactate.
In an embodiment, the chewing gum is sugarless.
2~ In an embodiment, the chewing gum is wax-free.
In an embodiment, the chewing gum is a low calorie chewing gum.
In an embodiment, the chewing gum contains other therapeutic agents.
In an embodiment, the chewing gum includes at least 40 mg of calcium lactate.
In an embodiment, the chewing gum is in the form of a stick.
In an embodiment, the chewing gum is in the form of a pellet.
In an embodiment, the chewing gum includes an additional therapeutic agent.
The present invention provides a composition and method for the remineralization of enamel. Pursuant to the present invention, sugar free chewing gum is provided that includes a therapeutically effective amount of calcium lactate.
It has been found that calcium lactate counteracts the decaying process.
Calcium lactate is believed to function by promoting remineralization of the tooth enamel caused by dental caries. Calcium lactate has been found to be an effective enamel remineralization agent that is acceptable from sensory and safety standpoints.
Pursuant to the present invention, calcium lactate can be used in chewing gum:
Chewing gum is an especially good vehicle for delivering calcium lactate because it can deliver the ingredient over prolonged periods of time. Additionally, chewing gum can be conveniently used almost anywhere, at anytime, as opposed to a rinse or dentifrices.
To this end, a method for remineralizing enamel is provided comprising the step of providing a chewing gum that includes a therapeutically effective amount of calcium lactate.
In an embodiment, two pieces of chewing gum are chewed at a time.
In an embodiment of the method, the gum is chewed at least twice a day.
In an embodiment of the method, the chewing gum produces a calcium ion concentration in the saliva of the mouth of the chewer of at least 200 ppm.
In an embodiment of the method, the gum is chewed for at least two minutes.
The present invention also provides a chewing gum for reducing the generation of dental caries comprising a water insoluble base, water soluble portion and flavor, and calcium lactate.
In an embodiment, the chewing gum is sugarless.
2~ In an embodiment, the chewing gum is wax-free.
In an embodiment, the chewing gum is a low calorie chewing gum.
In an embodiment, the chewing gum contains other therapeutic agents.
In an embodiment, the chewing gum includes at least 40 mg of calcium lactate.
In an embodiment, the chewing gum is in the form of a stick.
In an embodiment, the chewing gum is in the form of a pellet.
In an embodiment, the chewing gum includes an additional therapeutic agent.
An advantage of the present invention is to provide a method for preventing, or reducing the risk of, dental caries of the remineralization of enamel.
Another advantage of the present invention is to treat dental caries.
Additionally, an advantage of the present invention is to provide a chewing gum that can be used to improve dental health.
Further, an advantage of the present invention is to provide a chewing gum that does not have the sensory drawbacks of other sources of calcium.
Moreover, an advantage of the present invention is to provide an easy and enjoyable way to improve dental health.
Still further, an advantage of the present invention is to provide a composition and method for delivering a therapeutic agent over a prolonged period of time to the oral region.
Additional features and advantages of the present invention are described in, and will be apparent from, the detailed description of the presently preferred embodiments.
DETAILED DESCRIPTION OF THE
PRESENTLY PREFERRED EMBODIMENTS
The present invention provides a method and composition for remineralizing tooth enamel and thereby preventing and/or treating dental caries. Pursuant to the present invention, a chewing gum is provided that includes a therapeutically effective amount of calcium lactate. The chewing gum of the present invention, by including a therapeutically effective amount of calcium lactate, can improve dental health when chewed.
Calcium lactate is believed to function by the remineralization of tooth enamel.
Calcium lactate when provided in a chewing gum can produce a calcium ion concentration in the saliva during chewing which is effective to remineralized carious lesions in teeth. For example, it has been found that 80 mg of calcium lactate in chewing gum will produce saliva calcium levels greater than 500 parts per million, this level has been shown to remineralize teeth.
It is believed that the calcium ion concentration in the saliva should be above 200 ppm in order to initiate the remineralization process. Preferably the calcium ion concentration should be above 350 ppm and most preferably above 500 ppm. These levels should be provided for at least one minute, preferably more than two minutes, and most preferably more than four minutes upon chewing the gum.
It has been found that these levels can be accomplished by the inclusion of at least 40 mg, preferably at least 60 mg and most preferably at least 80 mg of calcium lactate in a piece of chewing gum. In some cases, it may be desirable to divide the prescribed dosage among two or more smaller pieces of gum which are intended to be chewed together.
In another embodiment of the invention, a method for the remineralization of carious lesions in teeth is provided that comprises providing a sugarless chewing gum comprising calcium lactate. The gum is chewed for at least two minutes (preferably at least 5 minutes and most preferably at least 20 minutes) whereby the calcium is released by the gum in a quantity sufficient to produce a calcium concentration which is effective to remineralized the carious lesions. This treatment is repeated at least twice, preferably at least three times, and most preferably at least five times daily until the lesion has been 1 S remineralized.
The chewing gum composition may be any chewing gum formula and most preferably a sugarless formulation. Such formulas typically contain a major amount of a sugar alcohol bulking agent, a substantial portion of gum base, minor amounts of syrups, softeners, flavors, color and high intensity sweeteners. Low calorie gums which contain reduced levels of sugar alcohols and increased levels of base and/or low calorie or calorie-free bulking agents are also anticipated. The product may be formed into tabs, sticks, chunks or coated pellets. A piece size of 1 to 4 grams is preferred.
As previously mentioned, with smaller pieces sizes, it may be desirable to split the calcium lactate dosage between two or more pieces to reduce the concentration for improved sensory acceptability.
Chewing gum generally consists of a water insoluble gum base, a water soluble portion, and flavors. The water soluble portion dissipates with a portion of the flavor over a period of time during chewing. The gum base portion is retained in the mouth throughout the chew.
The insoluble gum base generally comprises elastomers, resins, fats and oils, softeners, and inorganic fillers. The gum base may or may not include wax. The -S-insoluble gum base can constitute approximately 5 to about 95 percent, by weight, of the chewing gum, more commonly, the gum base comprises 10 to about 50 percent of the gum, and in some preferred embodiments, 20 to about 35 percent, by weight, of the chewing gum.
In an embodiment, the chewing gum base of the present invention contains about 20 to about 60 weight percent synthetic elastomer, 0 to about 30 weight percent natural elastomer, about 5 to about 55 weight percent elastomer plasticizer, about 4 to about 35 weight percent filler, about S to about 35 weight percent softener, and optional minor amounts (about one percent or less) of miscellaneous ingredients such as colorants, antioxidants, etc.
Synthetic elastomers may include, but are not limited to, polyisobutylene with GPC weight average molecular weight of about 10,000 to about 95,000, isobutylene-isoprene copolymer (butyl elastomer), styrene-butadiene copolymers having styrene-butadiene ratios of about 1:3 to about 3:1, polyvinyl acetate having GPC
weight average molecular weight of about 2,000 to about 90,000, polyisoprene, polyethylene, vinyl acetate-vinyl laurate copolymer having vinyl laurate content of about 5 to about 50 percent by weight of the copolymer, and combinations thereof.
Preferred ranges are, for polyisobutylene, 50,000 to 80,000 GPC weight average molecular weight, for styrene-butadiene, l:l to 1:3 bound styrene-butadiene, for polyvinyl acetate, 10,000 to 65,000 GPC weight average molecular weight with the higher molecular weight polyvinyl acetates typically used in bubble gum base, and for vinyl acetate-vinyl laurate, vinyl laurate content of 10-45 percent.
Natural elastomers may include natural rubber such as smoked or liquid latex and guayule as well as natural gums such as jelutong, lechi caspi, perillo, sorva, massaranduba balata, massaranduba chocolate, nispero, rosindinha, chicle, gutta hang kang, and combinations thereof. The preferred synthetic elastomer and natural elastomer concentrations vary depending on whether the chewing gum in which the base is used is abhesive or conventional, bubble gum or regular gum, as discussed below.
Preferred natural elastomers include jelutong, chide, sorva and massaranduba balata.
Elastomer plasticizers may include, but are not limited to, natural rosin esters such as glycerol esters of partially hydrogenated rosin, glycerol esters polymerized rosin, glycerol esters of partially dimerized rosin, glycerol esters of rosin, pentaerythritol esters of partially hydrogenated rosin, methyl and partially hydrogenated methyl esters of rosin, pentaerythritol esters of rosin; synthetics such as terpene resins derived from alpha-pinene, beta-pinene, and/or d-limonene; and any suitable combinations of the foregoing.
S the preferred elastomer plasticizers will also vary depending on the specific application, and on the type of elastomer which is used.
Fillers/texturizers may include magnesium and calcium carbonate, ground limestone, silicate types such as magnesium and aluminum silicate, clay, alumina, talc, titanium oxide, mono-, di- and tri-calcium phosphate, cellulose polymers, such as wood, and combinations thereof.
Softeners/emulsifiers may include tallow, hydrogenated tallow, hydrogenated and partially hydrogenated vegetable oils, cocoa butter, glycerol monostearate, glycerol triacetate, lecithin, mono-, di- and triglycerides, acetylated monoglycerides, fatty acids (e.g. stearic, palmitic, oleic and linoleic acids), and combinations thereof.
Colorants and whiteners may include FD&C-type dyes and lakes, fruit and vegetable extracts, titanium dioxide, and combinations thereof.
The base may or may not include wax. An example of a wax-free gum base is disclosed in U.S. Patent No. 5,286,500, the disclosure of which is incorporated herein by reference.
In addition to a water insoluble gum base portion, a typical chewing gum composition includes a water soluble bulk portion and one or more flavoring agents. The water soluble portion can include bulk sweeteners, high intensity sweeteners, flavoring agents, softeners, emulsifiers, colors, acidulants, fillers, antioxidants, and other components that provide desired attributes.
Softeners are added to the chewing gum in order to optimize the chewability and mouth feel of the gum. The softeners, which are also known as plasticizers and plasticizing agents, generally constitute between approximately 0.5 to about 1 S% by weight of the chewing gum. The softeners may include glycerin, lecithin, and combinations thereof. Aqueous sweetener solutions such as those containing sorbitol, hydrogenated starch hydrolysates, corn syrup and combinations thereof, may also be used as softeners and binding agents in chewing gum.
w0 00/42861 PCT/US00/01733 Bulk sweeteners include both sugar and sugarless components. Bulk sweeteners typically constitute 5 to about 95% by weight of the chewing gum, more typically, 20 to 80% by weight, and more commonly, 30 to 60% by weight of the gum.
Sugar sweeteners generally include saccharide-containing components commonly known in the chewing gum art, including, but not limited to, sucrose, dextrose, maltose, dextrin, dried invert sugar, fructose, levulose, galactose, corn syrup solids, and the like, alone or in combination.
Sugarless sweeteners include, but are not limited to, sugar alcohols such as sorbitol, mannitol, xylitol, hydrogenated starch hydrolysates, maltitol, and the like, alone or in combination.
High intensity artificial sweeteners can also be used, alone or in combination with the above. Preferred sweeteners include, but are not limited to sucralose, aspartame, salts of acesulfame, alitame, saccharin and its salts, cyclamic acid and its salts, glycyrrhizin, dihydrochalcones, thaumatin, monellin, and the like, alone or in combination.
In order to provide longer lasting sweetness and flavor perception, it may be desirable to encapsulate or otherwise control the release of at least a portion of the artificial sweetener. Such techniques as wet granulation, wax granulation, spray drying, spray chilling, fluid bed coating, coacervation, and fiber extension may be used to achieve the desired release characteristics.
Usage level of the artificial sweetener will vary greatly and will depend on such factors as potency of the sweetener, rate of release, desired sweetness of the product, level and type of flavor used and cost considerations. Thus, the active level of artificial sweetener may vary from 0.02 to about 8%. When carriers used for encapsulation are included, the usage level of the encapsulated sweetener will be proportionately higher.
Combinations of sugar and/or sugarless sweeteners may be used in chewing gum.
Additionally, the softener may also provide additional sweetness such as with aqueous sugar or alditol solutions.
If a low calorie gum is desired, a low caloric bulking agent can be used.
Example of low caloric bulking agents include: polydextrose; Raftilose, Raftilin;
Fructooligosaccharides (NutraFlora); Palatinose oligosaccharide; Guar Gum Hydrolysate (Sun Fiber); or indigestible dextrin (Fibersol). However, other low calorie bulking agents _g_ can be used.
A variety of flavoring agents can be used. The flavor can be used in amounts of approximately 0.1 to about 15 weight percent of the gum, and preferably, 0.2 to 5%.
Flavoring agents may include essential oils, synthetic flavors or mixtures thereof including, but not limited to, oils derived from plants and fruits such as citrus oils, fruit essences, peppermint oil, spearmint oil, other mint oils, clove oil, oil of wintergreen, anise and the like. Artificial flavoring agents and components may also be used. Natural and artificial flavoring agents may be combined in any sensorially acceptable fashion.
Additional oral health ingredients may be added including but not limited to, antiplaque/anti-gingivitis agents (such as chlorhexidine, CPC, triclosan), pH
control agents (including Urea and buffers,) other inorganic components for tarter or caries control (phosphates, fluoride) and biological agents (antibodies, enzymes).
The only requirement is that the agents be safe and effective and that they do not react undesirably with each other such as may happen with phosphate salts.
Preferably the calcium lactate is mixed into the chewing gum mass but it may also be added to a coating syrup or used as a dry charge in a coating process in the case of a coated chewing gum.
The following examples, which as of this time have not been made, illustrate some embodiments of the invention. Of course, many others are possible.
EXAMPLES
Gum Base 30.0% 32.60% 30.0% 70.0%
Sorbitol 40.0 - 25.4 10.4 Maltitol - 30.00 - -Xylitol 0.5 15.00 30.0 -Mannitol 7.0 5.00 2.0 2.0 Calcium Lactate 3.0 4.00 4.0 6.0 Aspartame 0.5 - 0.2 -Acesulfame K - 0.15 0.1 -Sucralose - 0.15 - 0.2 Alitame - - 0.1 -Neotame - - - 0.1 Sorbitol Solution 15.0 - 5.0 -(70% solids) Hydrogenated Starch- 9.00 - 5.0 Hydrolysate Syrup (85% solids) Glycerin 3.0 3.00 2.0 5.0 Color - 0.10 0.2 0.3 Flavor 1.0 1.00 1.0 1.0 (Spearmint)(Cinnamon)(Peppermint)(Wintergreen) Total 100% 100% 100% 100%
Form 3g stick 3g stick 2g tab lg tab EXAMPLES
Gum Base 25.0% 35.00% 35.0% 30.0%
Sorbitol 31.9 - 35.0 39.50%
Polydextrose - 40.88 - -Xylitol 15.0 - 5.0 5.00 Mannitol 5.0 5.00 5.0 4.00 Calcium Lactate 3.0 2.00 4.0 4.00 10Aspartame 0.5 0.50 0.3 0.50 Chlorhexidine - 0.17 - -Triclosan - 0.25 - -Urea 3.5 - - 0.50 S. Mutans Monclonal- - - 0.50 15Antibodies Glycerin 5.0 5.00 5.0 15.00 Hydrogenated Starch10.0 10.00 9.9 -Hydrolysate Syrup (85% solids) 20Color 0.1 0.20 0.1 0.15 Flavor 1.0 1.00 0.7 0.85 (Sweet Fruit)(Peppermint)(Menthol) (Spearmint) Total 100.0% 100.00% 100.0% 100.00%
Form 3g stick 3g stick lg pellet 3g stick center Notes on Examples:
25 Examples 4 and 8 are low caloric chewing gums.
Example 9 may be coated with xylitol, sorbitol, palatinit or maltitol with added chlorhexidine, triclosan and/or cetylpyridinium chloride (CPC). Recommended dose is two pellets.
In-vitro testing was conducted to determine what level of calcium in saliva would remineralize softened tooth enamel. Enamel specimens were removed from extracted human teeth, polished and decalcified by exposure to O.1M lactic acid solution. This treatment resulted in lesions with a surface hardness range of 25 to 45 Vickers Hardness Number (VHN) and an average lesion depth of 40-70 microns.
Solutions of calcium and fluoride in artificial saliva (prepared from a formula in Caries Research, 16:201, 1982) were prepared to treat the enamel. The saliva formula includes l.SmM (40 ppm) of calcium per liter. Two calcium levels were tested, 0 and 500 ppm and each level was prepared with 0, 0.05 and 0.10 ppm fluoride to simulate the effect of tooth brushing. The "Zero" calcium level had no calcium added to the 40 ppm already present. The 500 ppm calcium level had 460 ppm additional calcium to bring the total concentration up to S00 ppm. The six solutions thus prepared are summarized in Table 1.
Table 1 Solution Fluoride (ppm) Calcium (ppm) 3 0.05 0 4 0.05 500 5 0.10 0 6 0.10 500 Enamel samples were exposed to 20 minutes of acid challenge followed by 60 minutes of one calcium/fluoride solution (above) then 30 minutes of pure saliva. This cycle was repeated three times daily, four days per week for 3 weeks. The samples were tested for hardness after each week. Each treatment was performed on 12 samples. The results are reported in Table 2.
Table Change in Hardness Baseline One Two Three VHN Week Week Week Soln.F Ca n MeanS.D.n MeanS.D.n MeanS.D.n MeanS.D.
(PPm)(PPm) I 0 0 12 36.957.9612 3.343.6512 5.075.94I2 S.8SS.4S
2 0 S00 12 35.798.5212 7.234.7012 10.935.6312 11.607.70 3 ~ 0 I 38.038.53I 3.606.42I 7.946.05I 7.74IO.IS
O.OS I I I I
4 O.OSS00 12 33.296.2412 6.IS3.7012 13.7912.0912 IS.925.38 S O.I 0 12 33.958.3012 937 5.08I2 10.826.0812 12.656.40 -..- ..~ _..
-.
rb OI ~ 12 _37.526.2512 10.144.9612 13.284.7R12 16.999.12 ~ 500 Analysis of variance was used to determine the contribution of the two variables (fluoride and calcium) to the remineralization effect. The results are given as Tables 3 and 4.
Table 3 Change in VHN Hardness Due to Fluoride (Comparison Groups*) F (ppm) Week 1 Week 2 Week 3 0.00 5.27(A) 8.01 (B) 8.72(C) 0.05 4.88(A) 10.88(B) 11.88 (C D) 0.10 9.76 12.04(B) 14.82(D) *Results pairwise comparisons of treatments/effects.arked with of Groups m the same letter did not differ significantly (p<0.05).
Table 4 Change in VEIN Hardness Due to Calcium (p values **) Ca (ppm)Week 1 Week 2 Week 3 0 5.43 7.97 8.77 500 7.84 (0.0389) 12.65 (0.0079) 14.84 (0.0012) ** Probability that the difference between 0 and 500 ppm values is due totally to chance.
From this analysis it was concluded that fluoride had little effect on remineralization but that 500 ppm calcium in saliva significantly increased remineralization of decalcified enamel over time. It is very likely that lower levels would also be effective given the magnitude of the effect and the strength of the statistical S significance.
Four chewing gum compositions were prepared according to the formulas of Examples 11, 12, 13, and 14.
Table 5 Example 11 Example Example Example Gum Base 31.40% 32.40% 32.40 32.40 Sorbitol 38.78 38.75 41.75 41.75 Xylitol 15.60 15.60 15.60 15.60 Mannitol 4.00 4.00 4.00 4.00 Glycerin 3.00 3.00 3.00 3.00 Calcium Lactate4.00 3.00 - -Flavor 2.40 2.40 2.40 2.40***
Encapsulated 0.59 0.63 0.63 0.63 Acesulfame K
Encapsulated 0.12 0.12 0.12 0.12 Aspartame Acesulfame K 0.05 0.04 0.04 0.04 Red Color 0.06 0.06 0.06 0.06 Total 100.00 100.00 100.00 100.00 Form 2.Og Tab 2.7g Stick2.Og Tab 2.7g Stick (Inventive) (Inventive)(Comparative)(Comparative) Calcium Lactate 80mg 8lmg 0 0 per piece *** Example 14 used a different flavor from the other three Examples.
Eight volunteers chewed the gums of Examples 1 l and 12 for six minutes with saliva samples collected over two minute intervals. The saliva samples were analyzed for calcium by Direct Current Plasma. The two products delivered similar calcium levels reported in Table 6.
Table 6 Salivary Calcium Concentration (ppm) Time (min) Example 11 Example 12 Base line (no gum) 70 82 To demonstrate the sensory acceptability of the calcium lactate, consumer blind taste tests were run using Examples 11, 12, 13 and 14. Eighty children (6-10 years old, 50:50 male:female) rated each sample on a five point scale ("5" being the best rating) for overall preference. The results were:
Example Example 12 Example 13 Example 14 Tab with Stick with 3% Tab Control Stick 4% Control Calcium Calcium For Ex. 11 For Ex. 12 Lactate Lactate Overall 4.23 4.38 4.28 4.49 Preference ("5" = best) Based on these results it was concluded that calcium lactate had little or no effect on consumer preference. Note that the higher score for Ex. 14 may have been due to its use of a different flavor from the other samples.
It should be understood that various changes and modifications to the presently preferred embodiments described herein will be apparent to those skilled in the art. Such changes and modifications can be made without departing from the spirit and scope of the present invention and without diminishing its intended advantages. It is therefore intended that such changes and modifications be covered by the appended claims.
Another advantage of the present invention is to treat dental caries.
Additionally, an advantage of the present invention is to provide a chewing gum that can be used to improve dental health.
Further, an advantage of the present invention is to provide a chewing gum that does not have the sensory drawbacks of other sources of calcium.
Moreover, an advantage of the present invention is to provide an easy and enjoyable way to improve dental health.
Still further, an advantage of the present invention is to provide a composition and method for delivering a therapeutic agent over a prolonged period of time to the oral region.
Additional features and advantages of the present invention are described in, and will be apparent from, the detailed description of the presently preferred embodiments.
DETAILED DESCRIPTION OF THE
PRESENTLY PREFERRED EMBODIMENTS
The present invention provides a method and composition for remineralizing tooth enamel and thereby preventing and/or treating dental caries. Pursuant to the present invention, a chewing gum is provided that includes a therapeutically effective amount of calcium lactate. The chewing gum of the present invention, by including a therapeutically effective amount of calcium lactate, can improve dental health when chewed.
Calcium lactate is believed to function by the remineralization of tooth enamel.
Calcium lactate when provided in a chewing gum can produce a calcium ion concentration in the saliva during chewing which is effective to remineralized carious lesions in teeth. For example, it has been found that 80 mg of calcium lactate in chewing gum will produce saliva calcium levels greater than 500 parts per million, this level has been shown to remineralize teeth.
It is believed that the calcium ion concentration in the saliva should be above 200 ppm in order to initiate the remineralization process. Preferably the calcium ion concentration should be above 350 ppm and most preferably above 500 ppm. These levels should be provided for at least one minute, preferably more than two minutes, and most preferably more than four minutes upon chewing the gum.
It has been found that these levels can be accomplished by the inclusion of at least 40 mg, preferably at least 60 mg and most preferably at least 80 mg of calcium lactate in a piece of chewing gum. In some cases, it may be desirable to divide the prescribed dosage among two or more smaller pieces of gum which are intended to be chewed together.
In another embodiment of the invention, a method for the remineralization of carious lesions in teeth is provided that comprises providing a sugarless chewing gum comprising calcium lactate. The gum is chewed for at least two minutes (preferably at least 5 minutes and most preferably at least 20 minutes) whereby the calcium is released by the gum in a quantity sufficient to produce a calcium concentration which is effective to remineralized the carious lesions. This treatment is repeated at least twice, preferably at least three times, and most preferably at least five times daily until the lesion has been 1 S remineralized.
The chewing gum composition may be any chewing gum formula and most preferably a sugarless formulation. Such formulas typically contain a major amount of a sugar alcohol bulking agent, a substantial portion of gum base, minor amounts of syrups, softeners, flavors, color and high intensity sweeteners. Low calorie gums which contain reduced levels of sugar alcohols and increased levels of base and/or low calorie or calorie-free bulking agents are also anticipated. The product may be formed into tabs, sticks, chunks or coated pellets. A piece size of 1 to 4 grams is preferred.
As previously mentioned, with smaller pieces sizes, it may be desirable to split the calcium lactate dosage between two or more pieces to reduce the concentration for improved sensory acceptability.
Chewing gum generally consists of a water insoluble gum base, a water soluble portion, and flavors. The water soluble portion dissipates with a portion of the flavor over a period of time during chewing. The gum base portion is retained in the mouth throughout the chew.
The insoluble gum base generally comprises elastomers, resins, fats and oils, softeners, and inorganic fillers. The gum base may or may not include wax. The -S-insoluble gum base can constitute approximately 5 to about 95 percent, by weight, of the chewing gum, more commonly, the gum base comprises 10 to about 50 percent of the gum, and in some preferred embodiments, 20 to about 35 percent, by weight, of the chewing gum.
In an embodiment, the chewing gum base of the present invention contains about 20 to about 60 weight percent synthetic elastomer, 0 to about 30 weight percent natural elastomer, about 5 to about 55 weight percent elastomer plasticizer, about 4 to about 35 weight percent filler, about S to about 35 weight percent softener, and optional minor amounts (about one percent or less) of miscellaneous ingredients such as colorants, antioxidants, etc.
Synthetic elastomers may include, but are not limited to, polyisobutylene with GPC weight average molecular weight of about 10,000 to about 95,000, isobutylene-isoprene copolymer (butyl elastomer), styrene-butadiene copolymers having styrene-butadiene ratios of about 1:3 to about 3:1, polyvinyl acetate having GPC
weight average molecular weight of about 2,000 to about 90,000, polyisoprene, polyethylene, vinyl acetate-vinyl laurate copolymer having vinyl laurate content of about 5 to about 50 percent by weight of the copolymer, and combinations thereof.
Preferred ranges are, for polyisobutylene, 50,000 to 80,000 GPC weight average molecular weight, for styrene-butadiene, l:l to 1:3 bound styrene-butadiene, for polyvinyl acetate, 10,000 to 65,000 GPC weight average molecular weight with the higher molecular weight polyvinyl acetates typically used in bubble gum base, and for vinyl acetate-vinyl laurate, vinyl laurate content of 10-45 percent.
Natural elastomers may include natural rubber such as smoked or liquid latex and guayule as well as natural gums such as jelutong, lechi caspi, perillo, sorva, massaranduba balata, massaranduba chocolate, nispero, rosindinha, chicle, gutta hang kang, and combinations thereof. The preferred synthetic elastomer and natural elastomer concentrations vary depending on whether the chewing gum in which the base is used is abhesive or conventional, bubble gum or regular gum, as discussed below.
Preferred natural elastomers include jelutong, chide, sorva and massaranduba balata.
Elastomer plasticizers may include, but are not limited to, natural rosin esters such as glycerol esters of partially hydrogenated rosin, glycerol esters polymerized rosin, glycerol esters of partially dimerized rosin, glycerol esters of rosin, pentaerythritol esters of partially hydrogenated rosin, methyl and partially hydrogenated methyl esters of rosin, pentaerythritol esters of rosin; synthetics such as terpene resins derived from alpha-pinene, beta-pinene, and/or d-limonene; and any suitable combinations of the foregoing.
S the preferred elastomer plasticizers will also vary depending on the specific application, and on the type of elastomer which is used.
Fillers/texturizers may include magnesium and calcium carbonate, ground limestone, silicate types such as magnesium and aluminum silicate, clay, alumina, talc, titanium oxide, mono-, di- and tri-calcium phosphate, cellulose polymers, such as wood, and combinations thereof.
Softeners/emulsifiers may include tallow, hydrogenated tallow, hydrogenated and partially hydrogenated vegetable oils, cocoa butter, glycerol monostearate, glycerol triacetate, lecithin, mono-, di- and triglycerides, acetylated monoglycerides, fatty acids (e.g. stearic, palmitic, oleic and linoleic acids), and combinations thereof.
Colorants and whiteners may include FD&C-type dyes and lakes, fruit and vegetable extracts, titanium dioxide, and combinations thereof.
The base may or may not include wax. An example of a wax-free gum base is disclosed in U.S. Patent No. 5,286,500, the disclosure of which is incorporated herein by reference.
In addition to a water insoluble gum base portion, a typical chewing gum composition includes a water soluble bulk portion and one or more flavoring agents. The water soluble portion can include bulk sweeteners, high intensity sweeteners, flavoring agents, softeners, emulsifiers, colors, acidulants, fillers, antioxidants, and other components that provide desired attributes.
Softeners are added to the chewing gum in order to optimize the chewability and mouth feel of the gum. The softeners, which are also known as plasticizers and plasticizing agents, generally constitute between approximately 0.5 to about 1 S% by weight of the chewing gum. The softeners may include glycerin, lecithin, and combinations thereof. Aqueous sweetener solutions such as those containing sorbitol, hydrogenated starch hydrolysates, corn syrup and combinations thereof, may also be used as softeners and binding agents in chewing gum.
w0 00/42861 PCT/US00/01733 Bulk sweeteners include both sugar and sugarless components. Bulk sweeteners typically constitute 5 to about 95% by weight of the chewing gum, more typically, 20 to 80% by weight, and more commonly, 30 to 60% by weight of the gum.
Sugar sweeteners generally include saccharide-containing components commonly known in the chewing gum art, including, but not limited to, sucrose, dextrose, maltose, dextrin, dried invert sugar, fructose, levulose, galactose, corn syrup solids, and the like, alone or in combination.
Sugarless sweeteners include, but are not limited to, sugar alcohols such as sorbitol, mannitol, xylitol, hydrogenated starch hydrolysates, maltitol, and the like, alone or in combination.
High intensity artificial sweeteners can also be used, alone or in combination with the above. Preferred sweeteners include, but are not limited to sucralose, aspartame, salts of acesulfame, alitame, saccharin and its salts, cyclamic acid and its salts, glycyrrhizin, dihydrochalcones, thaumatin, monellin, and the like, alone or in combination.
In order to provide longer lasting sweetness and flavor perception, it may be desirable to encapsulate or otherwise control the release of at least a portion of the artificial sweetener. Such techniques as wet granulation, wax granulation, spray drying, spray chilling, fluid bed coating, coacervation, and fiber extension may be used to achieve the desired release characteristics.
Usage level of the artificial sweetener will vary greatly and will depend on such factors as potency of the sweetener, rate of release, desired sweetness of the product, level and type of flavor used and cost considerations. Thus, the active level of artificial sweetener may vary from 0.02 to about 8%. When carriers used for encapsulation are included, the usage level of the encapsulated sweetener will be proportionately higher.
Combinations of sugar and/or sugarless sweeteners may be used in chewing gum.
Additionally, the softener may also provide additional sweetness such as with aqueous sugar or alditol solutions.
If a low calorie gum is desired, a low caloric bulking agent can be used.
Example of low caloric bulking agents include: polydextrose; Raftilose, Raftilin;
Fructooligosaccharides (NutraFlora); Palatinose oligosaccharide; Guar Gum Hydrolysate (Sun Fiber); or indigestible dextrin (Fibersol). However, other low calorie bulking agents _g_ can be used.
A variety of flavoring agents can be used. The flavor can be used in amounts of approximately 0.1 to about 15 weight percent of the gum, and preferably, 0.2 to 5%.
Flavoring agents may include essential oils, synthetic flavors or mixtures thereof including, but not limited to, oils derived from plants and fruits such as citrus oils, fruit essences, peppermint oil, spearmint oil, other mint oils, clove oil, oil of wintergreen, anise and the like. Artificial flavoring agents and components may also be used. Natural and artificial flavoring agents may be combined in any sensorially acceptable fashion.
Additional oral health ingredients may be added including but not limited to, antiplaque/anti-gingivitis agents (such as chlorhexidine, CPC, triclosan), pH
control agents (including Urea and buffers,) other inorganic components for tarter or caries control (phosphates, fluoride) and biological agents (antibodies, enzymes).
The only requirement is that the agents be safe and effective and that they do not react undesirably with each other such as may happen with phosphate salts.
Preferably the calcium lactate is mixed into the chewing gum mass but it may also be added to a coating syrup or used as a dry charge in a coating process in the case of a coated chewing gum.
The following examples, which as of this time have not been made, illustrate some embodiments of the invention. Of course, many others are possible.
EXAMPLES
Gum Base 30.0% 32.60% 30.0% 70.0%
Sorbitol 40.0 - 25.4 10.4 Maltitol - 30.00 - -Xylitol 0.5 15.00 30.0 -Mannitol 7.0 5.00 2.0 2.0 Calcium Lactate 3.0 4.00 4.0 6.0 Aspartame 0.5 - 0.2 -Acesulfame K - 0.15 0.1 -Sucralose - 0.15 - 0.2 Alitame - - 0.1 -Neotame - - - 0.1 Sorbitol Solution 15.0 - 5.0 -(70% solids) Hydrogenated Starch- 9.00 - 5.0 Hydrolysate Syrup (85% solids) Glycerin 3.0 3.00 2.0 5.0 Color - 0.10 0.2 0.3 Flavor 1.0 1.00 1.0 1.0 (Spearmint)(Cinnamon)(Peppermint)(Wintergreen) Total 100% 100% 100% 100%
Form 3g stick 3g stick 2g tab lg tab EXAMPLES
Gum Base 25.0% 35.00% 35.0% 30.0%
Sorbitol 31.9 - 35.0 39.50%
Polydextrose - 40.88 - -Xylitol 15.0 - 5.0 5.00 Mannitol 5.0 5.00 5.0 4.00 Calcium Lactate 3.0 2.00 4.0 4.00 10Aspartame 0.5 0.50 0.3 0.50 Chlorhexidine - 0.17 - -Triclosan - 0.25 - -Urea 3.5 - - 0.50 S. Mutans Monclonal- - - 0.50 15Antibodies Glycerin 5.0 5.00 5.0 15.00 Hydrogenated Starch10.0 10.00 9.9 -Hydrolysate Syrup (85% solids) 20Color 0.1 0.20 0.1 0.15 Flavor 1.0 1.00 0.7 0.85 (Sweet Fruit)(Peppermint)(Menthol) (Spearmint) Total 100.0% 100.00% 100.0% 100.00%
Form 3g stick 3g stick lg pellet 3g stick center Notes on Examples:
25 Examples 4 and 8 are low caloric chewing gums.
Example 9 may be coated with xylitol, sorbitol, palatinit or maltitol with added chlorhexidine, triclosan and/or cetylpyridinium chloride (CPC). Recommended dose is two pellets.
In-vitro testing was conducted to determine what level of calcium in saliva would remineralize softened tooth enamel. Enamel specimens were removed from extracted human teeth, polished and decalcified by exposure to O.1M lactic acid solution. This treatment resulted in lesions with a surface hardness range of 25 to 45 Vickers Hardness Number (VHN) and an average lesion depth of 40-70 microns.
Solutions of calcium and fluoride in artificial saliva (prepared from a formula in Caries Research, 16:201, 1982) were prepared to treat the enamel. The saliva formula includes l.SmM (40 ppm) of calcium per liter. Two calcium levels were tested, 0 and 500 ppm and each level was prepared with 0, 0.05 and 0.10 ppm fluoride to simulate the effect of tooth brushing. The "Zero" calcium level had no calcium added to the 40 ppm already present. The 500 ppm calcium level had 460 ppm additional calcium to bring the total concentration up to S00 ppm. The six solutions thus prepared are summarized in Table 1.
Table 1 Solution Fluoride (ppm) Calcium (ppm) 3 0.05 0 4 0.05 500 5 0.10 0 6 0.10 500 Enamel samples were exposed to 20 minutes of acid challenge followed by 60 minutes of one calcium/fluoride solution (above) then 30 minutes of pure saliva. This cycle was repeated three times daily, four days per week for 3 weeks. The samples were tested for hardness after each week. Each treatment was performed on 12 samples. The results are reported in Table 2.
Table Change in Hardness Baseline One Two Three VHN Week Week Week Soln.F Ca n MeanS.D.n MeanS.D.n MeanS.D.n MeanS.D.
(PPm)(PPm) I 0 0 12 36.957.9612 3.343.6512 5.075.94I2 S.8SS.4S
2 0 S00 12 35.798.5212 7.234.7012 10.935.6312 11.607.70 3 ~ 0 I 38.038.53I 3.606.42I 7.946.05I 7.74IO.IS
O.OS I I I I
4 O.OSS00 12 33.296.2412 6.IS3.7012 13.7912.0912 IS.925.38 S O.I 0 12 33.958.3012 937 5.08I2 10.826.0812 12.656.40 -..- ..~ _..
-.
rb OI ~ 12 _37.526.2512 10.144.9612 13.284.7R12 16.999.12 ~ 500 Analysis of variance was used to determine the contribution of the two variables (fluoride and calcium) to the remineralization effect. The results are given as Tables 3 and 4.
Table 3 Change in VHN Hardness Due to Fluoride (Comparison Groups*) F (ppm) Week 1 Week 2 Week 3 0.00 5.27(A) 8.01 (B) 8.72(C) 0.05 4.88(A) 10.88(B) 11.88 (C D) 0.10 9.76 12.04(B) 14.82(D) *Results pairwise comparisons of treatments/effects.arked with of Groups m the same letter did not differ significantly (p<0.05).
Table 4 Change in VEIN Hardness Due to Calcium (p values **) Ca (ppm)Week 1 Week 2 Week 3 0 5.43 7.97 8.77 500 7.84 (0.0389) 12.65 (0.0079) 14.84 (0.0012) ** Probability that the difference between 0 and 500 ppm values is due totally to chance.
From this analysis it was concluded that fluoride had little effect on remineralization but that 500 ppm calcium in saliva significantly increased remineralization of decalcified enamel over time. It is very likely that lower levels would also be effective given the magnitude of the effect and the strength of the statistical S significance.
Four chewing gum compositions were prepared according to the formulas of Examples 11, 12, 13, and 14.
Table 5 Example 11 Example Example Example Gum Base 31.40% 32.40% 32.40 32.40 Sorbitol 38.78 38.75 41.75 41.75 Xylitol 15.60 15.60 15.60 15.60 Mannitol 4.00 4.00 4.00 4.00 Glycerin 3.00 3.00 3.00 3.00 Calcium Lactate4.00 3.00 - -Flavor 2.40 2.40 2.40 2.40***
Encapsulated 0.59 0.63 0.63 0.63 Acesulfame K
Encapsulated 0.12 0.12 0.12 0.12 Aspartame Acesulfame K 0.05 0.04 0.04 0.04 Red Color 0.06 0.06 0.06 0.06 Total 100.00 100.00 100.00 100.00 Form 2.Og Tab 2.7g Stick2.Og Tab 2.7g Stick (Inventive) (Inventive)(Comparative)(Comparative) Calcium Lactate 80mg 8lmg 0 0 per piece *** Example 14 used a different flavor from the other three Examples.
Eight volunteers chewed the gums of Examples 1 l and 12 for six minutes with saliva samples collected over two minute intervals. The saliva samples were analyzed for calcium by Direct Current Plasma. The two products delivered similar calcium levels reported in Table 6.
Table 6 Salivary Calcium Concentration (ppm) Time (min) Example 11 Example 12 Base line (no gum) 70 82 To demonstrate the sensory acceptability of the calcium lactate, consumer blind taste tests were run using Examples 11, 12, 13 and 14. Eighty children (6-10 years old, 50:50 male:female) rated each sample on a five point scale ("5" being the best rating) for overall preference. The results were:
Example Example 12 Example 13 Example 14 Tab with Stick with 3% Tab Control Stick 4% Control Calcium Calcium For Ex. 11 For Ex. 12 Lactate Lactate Overall 4.23 4.38 4.28 4.49 Preference ("5" = best) Based on these results it was concluded that calcium lactate had little or no effect on consumer preference. Note that the higher score for Ex. 14 may have been due to its use of a different flavor from the other samples.
It should be understood that various changes and modifications to the presently preferred embodiments described herein will be apparent to those skilled in the art. Such changes and modifications can be made without departing from the spirit and scope of the present invention and without diminishing its intended advantages. It is therefore intended that such changes and modifications be covered by the appended claims.
Claims (25)
1. A sugar free chewing gum for promoting the remineralization of tooth enamel comprising:
a water insoluble base portion;
a water soluble portion;
a flavor; and calcium lactate.
a water insoluble base portion;
a water soluble portion;
a flavor; and calcium lactate.
2. The chewing gum of Claim 1 wherein the chewing gum contains at least one other therapeutic agent.
3. The chewing gum of Claim 1 including at least 40 mg of calcium lactate.
4. The chewing gum of Claim 1 including at least 60 mg of calcium lactate.
5. The chewing gum of Claim 1 including at least 80 mg of calcium lactate.
6. The chewing gum of Claim 1 wherein the calcium lactate is divided among two or more pieces.
7. The chewing gum of Claim 1 wherein the gum is in the form of a stick.
8. The chewing gum of Claim 1 wherein the gum is in the form of a tab.
9. A method for promoting the remineralization of tooth enamel comprising the steps of chewing a chewing gum that includes a therapeutically effective amount of calcium lactate.
10. The method of Claim 9 wherein two pieces of chewing gum are chewed at a time.
11. The method of Claim 9 wherein the gum is chewed at least twice a day.
12. The method of Claim 9 wherein the chewing gum produces a calcium ion concentration in the saliva of the mouth of the chewer of at least 200 ppm.
13. The method of Claim 9 wherein the chewing gum produces a calcium ion concentration in the saliva of the mouth of the chewer of at least 350 ppm.
14. The method of Claim 9 wherein the chewing gum produces a calcium ion concentration in the saliva of the mouth of the chewer of at least 500 ppm.
15. The method of Claim 9 wherein a calcium ion concentration is maintained for at least 2 minutes.
16. A chewing gum for remineralizing tooth enamel comprising:
a water insoluble portion;
a water soluble portion;
a flavor; and sufficient calcium lactate to produce a calcium ion concentration in the mouth of the chewer of at least 200 ppm.
a water insoluble portion;
a water soluble portion;
a flavor; and sufficient calcium lactate to produce a calcium ion concentration in the mouth of the chewer of at least 200 ppm.
17. The chewing gum of Claim 16 wherein the chewing gum contains other therapeutic agents.
18. The chewing gum of Claim 16 including at least 40 mg of calcium lactate.
19. The chewing gum of Claim 16 including at least 60 mg of calcium lactate.
20. The chewing gum of Claim 16 including at least 80 mg of calcium lactate.
21. The chewing gum of Claim 16 wherein the gum is in the form of a stick.
22. The chewing gum of Claim 16 wherein the gum is in the form of a tab.
23. The chewing gum of Claim 16 wherein the gum is in the form of a stick wherein the calcium lactate is divided among two or more pieces.
24. The chewing gum of Claim 16 wherein the gum comprises sufficient calcium lactate to produce a calcium ion concentration in the mouth of the chewer of at least 350 ppm.
25. The chewing gum of Claim 16 wherein the gum comprises sufficient calcium lactate to produce a calcium ion concentration in the mouth of the chewer of at least 500 ppm.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11719599P | 1999-01-26 | 1999-01-26 | |
US60/117,195 | 1999-01-26 | ||
PCT/US2000/001733 WO2000042861A1 (en) | 1999-01-26 | 2000-01-21 | Chewing gum with dental health benefits employing calcium lactate |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2359641A1 true CA2359641A1 (en) | 2000-07-27 |
Family
ID=22371445
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002359641A Abandoned CA2359641A1 (en) | 1999-01-26 | 2000-01-21 | Chewing gum with dental health benefits employing calcium lactate |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1146792A4 (en) |
AU (1) | AU2626700A (en) |
CA (1) | CA2359641A1 (en) |
WO (1) | WO2000042861A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001028503A1 (en) * | 1999-10-19 | 2001-04-26 | The Nutrasweet Company | PERSONAL CARE PRODUCTS USING N-[N-(3,3-DIMETHYLBUTYL)-1-α-ASPARTYL]-L-PHENYLALANINE METHYL ESTER |
US20030104099A1 (en) * | 2001-10-12 | 2003-06-05 | Lee Willy W. | Mineral delivery systems and methods |
EP1693086A1 (en) * | 2005-01-28 | 2006-08-23 | Gumlink A/S | Multi functional oral care chewing gum |
WO2006079343A1 (en) * | 2005-01-28 | 2006-08-03 | Gumlink A/S | A compressed chewing gum table |
EP1693085A1 (en) * | 2005-01-28 | 2006-08-23 | Gumlink A/S | A kit for cleaning teeth by chewing of a set of chewing gum pieces |
US20060182693A1 (en) | 2005-01-28 | 2006-08-17 | Gumlink A/S | Chewing gum possessing tooth cleaning effect and a teeth cleaning method |
EP1685875A1 (en) * | 2005-01-28 | 2006-08-02 | Gumlink A/S | Multi functional oral care chewing gum |
PL1845960T3 (en) | 2005-01-28 | 2009-06-30 | Gumlink As | A tooth cleaning kit comprising at least one set of chewing gum pieces |
EP1688162A1 (en) * | 2005-01-28 | 2006-08-09 | Gumlink A/S | Multi functional oral care chewing gum possessing tooth cleaning effects |
WO2012001347A1 (en) | 2010-06-29 | 2012-01-05 | Ucl Business Plc | Products with oral health benefits |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR486712A (en) * | 1916-04-10 | 1918-05-01 | Frederick Chase Bargar | Improvements to fire extinguishers |
US5378131A (en) * | 1993-02-18 | 1995-01-03 | The Wm. Wrigley Jr. Company | Chewing gum with dental health benefits employing calcium glycerophosphate |
US5645853A (en) * | 1995-08-08 | 1997-07-08 | Enamelon Inc. | Chewing gum compositions and the use thereof for remineralization of lesions in teeth |
CA2224274C (en) * | 1995-08-08 | 2001-07-31 | Enamelon, Inc. | Remineralizing products and methods for teeth |
US5833954A (en) * | 1996-08-20 | 1998-11-10 | American Dental Association Health Foundation | Anti-carious chewing gums, candies, gels, toothpastes and dentifrices |
US5958380A (en) * | 1997-07-07 | 1999-09-28 | Enamelon, Inc. | Chewing gum products and the use thereof for remineralizing subsurface dental lesions and for mineralizing exposed dentinal tubules |
-
2000
- 2000-01-21 AU AU26267/00A patent/AU2626700A/en not_active Abandoned
- 2000-01-21 CA CA002359641A patent/CA2359641A1/en not_active Abandoned
- 2000-01-21 EP EP00904525A patent/EP1146792A4/en not_active Withdrawn
- 2000-01-21 WO PCT/US2000/001733 patent/WO2000042861A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2000042861A1 (en) | 2000-07-27 |
EP1146792A4 (en) | 2005-07-20 |
AU2626700A (en) | 2000-08-07 |
EP1146792A1 (en) | 2001-10-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5378131A (en) | Chewing gum with dental health benefits employing calcium glycerophosphate | |
US6436369B2 (en) | Anti-plaque emulsions and products containing same | |
US5958380A (en) | Chewing gum products and the use thereof for remineralizing subsurface dental lesions and for mineralizing exposed dentinal tubules | |
US5645853A (en) | Chewing gum compositions and the use thereof for remineralization of lesions in teeth | |
US4150112A (en) | Plaque inhibiting composition and method | |
US6451290B2 (en) | Products and methods for the remineralization and prevention of demineralization of teeth | |
RU2417621C2 (en) | Calcium phosphate complex for acid containing candies | |
WO1997012607A1 (en) | Chewing gum product with plaque-inhibiting benefits | |
WO1994018939A1 (en) | Pre-brushing rinse composition | |
MX2008012520A (en) | Impact of calcium phosphate complex on dental caries. | |
EP1173154A1 (en) | Chewing gum with dental benefits including calcium in a food grade acid | |
US4170632A (en) | Plaque inhibiting compositions and method | |
CA2359641A1 (en) | Chewing gum with dental health benefits employing calcium lactate | |
US20070081950A1 (en) | Solid oral tooth whitening confectionary composition | |
US20100330000A1 (en) | Enzymes for treatment of gingivitis | |
AU2004201045B2 (en) | Chewing Gum with Dental Health Benefits Employing Calcium Lactate | |
AU2006200557A1 (en) | Chewing gum with dental health benefits employing calcium lactate | |
WO1997002009A1 (en) | Chewing-gum for the buccal hygiene and base gum for its preparation | |
AU2004201046A1 (en) | Chewing Gum with Dental Benefits Including Calcium in a Food Grade Acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |